Key result
TRACTION trial tests if CCTA is noninferior to ICA for interventional triage in NSTE-ACS.
Why the study?
In patients admitted with NSTE-ACS, it is uncertain whether CCTA is noninferior to ICA for determining the interventional strategy.
Does CCTA-based interventional triage prevent major adverse cardiac events compared to invasive coronary angiography in patients with NSTE-ACS?
RCT (n=2,300)
Open-label, assessor-blinded
1:1 block randomization
Yes
Does CCTA-based interventional triage prevent major adverse cardiac events compared to invasive coronary angiography in patients with NSTE-ACS?
The TRACTION trial is designed to determine whether a CCTA-first triage strategy is noninferior to routine invasive coronary angiography for clinical outcomes in patients with NSTE-ACS.
PURPOSE: In patients admitted with acute coronary syndrome, invasive coronary angiography (ICA) is performed to determine which patients need revascularization. Coronary computed tomography angiography (CCTA) offers a widely available, non-invasive alternative that could reduce patient discomfort, procedural risks, and healthcare costs. The current trial aims to determine whether CCTA is noninferior to ICA in determining the interventional strategy for patients admitted with non-ST elevation acute coronary syndrome (NSTE-ACS)(Central Illustration). METHODS: TRACTION (Team-based Interventional Triage in Acute Coronary Syndrome Based on Noninvasive Coronary Computed Tomography Angiography Versus Invasive Coronary Angiography) is a multicenter, randomized, open-label, noninferiority trial enrolling 2,300 patients. Patients hospitalized with non-ST elevation myocardial infarction or unstable angina with ischemic changes on ECG will be randomized 1:1 to CCTA vs ICA (standard of care). In the CCTA group, a Coronary Team reviews the CCTA and clinical information to determine the interventional strategy. The primary composite endpoint is major adverse cardiac events at 1 year, comprised of all-cause mortality, nonfatal myocardial infarction, hospitalization due to refractory angina, or hospitalization due to heart failure. Secondary outcomes include cardiovascular death, revascularization, symptom status, procedure-related adverse events, and resource utilization. The trial is designed to demonstrate noninferiority if the 95% confidence interval excludes an absolute risk difference of the primary endpoint larger than 5%. PERSPECTIVES: If CCTA is shown to be noninferior to ICA in patients admitted with NSTE-ACS, CCTA could become the preferred management in a large group of patients. This could result in fewer patients exposed to invasive procedures and improved resource utilization. CLINICALTRIALS: gov identifier: NCT06101862.
No takes yet. Share an insight, caveat, or question.
Sørgaard et al. (2025) conducted an RCT in Non-ST elevation acute coronary syndrome (NSTE-ACS) (n=2,300). Coronary computed tomography angiography (CCTA) vs. Invasive coronary angiography (ICA) was evaluated on Major adverse cardiac events at 1 year (all-cause mortality, nonfatal myocardial infarction, hospitalization with refractory angina, or hospitalization with heart failure). The TRACTION trial will determine if coronary computed tomography angiography is noninferior to invasive coronary angiography for interventional triage in non-ST elevation acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: